$SRNE 
Sorrento Therapeutics stock is a buy on the 50% chance of a #COVID19 antidote 
https://t.co/hpiJloUtXb  #Breakout $ALT$ARCT $GILD $VIR $BNTX $PFE #UAB  #Biotechnology #vaccine #Antibodies @business @WSJ @washingtonpost @BillGates @gatesfoundation  @NewYorkTimes11